Display Settings:

Format

Send to:

Choose Destination

    Clin Rheumatol. 2006 Feb;25(1):70-4. Epub 2005 May 18.

    Calcinosis cutis universalis in a patient with systemic lupus erythematosus.

    Tristano AG, Villarroel JL, Rodríguez MA, Millan A.

    Servicio de Medicina Interna, Hospital Dr. Domingo Luciani, Caracas, Venezuela. mjtristano@cantv.net

    Deposition of calcium salts in the skin and subcutaneous tissue occurs in a variety of rheumatic diseases, being most commonly associated with scleroderma, CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia), dermatomyositis, and overlap syndromes but is a rare complication of systemic lupus erythematosus (SLE). Calcinosis is classified into four subsets: dystrophic, metastatic, idiopathic, or calciphylaxis/iatrogenic. The pathophysiology of calcinosis cutis remains unclear. Our patient developed extensive areas of calcifications in the trunk and extremities (calcinosis universalis) 8 years after SLE diagnosis, which would correspond to a form of dystrophic calcification. No response was observed after treatment with oral diltiazem for 3 months. We review the literature on the pathogenesis and prevalence of calcinosis universalis in SLE.

    PMID: 15902514 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Diltiazem (Cardizem®, Cardizem® CD, Cardizem® LA, ...)

      Diltiazem is used to treat high blood pressure and to control angina (chest pain). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have...